Abstract
Obesity is a chronic condition that is also a risk factor of several other chronic conditions including type 2 diabetes. The effects of maternal obesity and type 2 diabetes on fetal development and offspring health are mediated through the transmission of epigenetic modifications in addition to the possible permanent changes of the organs caused by the intrauterine environment hypothesized by the Developmental Origins of Health and Disease (DOHaD) theory. Epigenetic modifications can be altered by environmental factors including dietary and lifestyle factors. The current priorities include identification and confirmation of the specific epigenetic biomarkers associated with obesity and type 2 diabetes in human subjects and identification of the dietary and lifestyle factors that contribute to each of the identified specific epigenetic biomarkers.
Publisher
Bentham Science Publishers Ltd.
Subject
General Biochemistry, Genetics and Molecular Biology
Reference38 articles.
1. Hales CM, Carroll MD, Fryar CD, Ogden CL.
Prevalence of Obesity Among Adults and Youth: United States, 2015-2016.
NCHS Data Brief
2017;
(288):
1-8.
2. Cirillo F, Catellani C, Sartori C, Lazzeroni P, Amarri S, Street ME.
Obesity, insulin resistance, and colorectal cancer: Could mirna dysregulation play a role?
Int J Mol Sci
2019;
20
(12)
: 2922.
3. Leitner DR, Frühbeck G, Yumuk V, et al.
Obesity and Type 2 Diabetes: Two Diseases with a Need for Combined Treatment Strategies - EASO Can Lead the Way.
Obes Facts
2017;
10
(5)
: 483-92.
4. Clausen TD, Mathiesen ER, Hansen T, et al.
Overweight and the metabolic syndrome in adult offspring of women with diet-treated gestational diabetes mellitus or type 1 diabetes.
J Clin Endocrinol Metab
2009;
94
(7)
: 2464-70.
5. De Pergola G, Silvestris F.
Obesity as a major risk factor for cancer.
J Obes
2013;
2013
: 1-11.